Drug Discovery

Review shows that antidepressants have significant effect when treating generalized anxiety disorder.

How snake venom, genomic data, and deep learning computation methods have combined to bring new advances in drug discovery.

With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?

Using AI to improve oncology care and find the right clinical trials for patients.

How understanding and manipulating senescence dynamics could optimize cancer therapies and improve patient outcomes.

How can you ensure your gene therapy research won’t be slowed down by synthesis problems?

Sitting Down With… Matthew Durdy, Chief Executive, Cell and Gene Therapy Catapult.

How unified assay protocols and advanced bioinformatics are refining our understanding of mitochondrial dysfunction in complex diseases.

What lies ahead for the future of pharma? Dennis van Rooji gives his view.

Proprietary nanovesicles technology has caught the eye of Eli Lilly. We find out why.